Condition

Meibomian Gland Dysfunction (2)

Dry Eye (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Azura Ophthalmics (2)

Collaborator

Cliantha Research (1)

Syneos Health (1)

The University of New South Wales (1)

Intervention

azr-md-001 high dose (1)

azr-md-001 low dose (1)

azr-md-001 mid dose (1)

azr-md-001 ointment/semi-solid drug (1)

azr-md-001 vehicle (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

meibomian gland dysfunction

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Meibomian Gland Dysfunction Trial in Sydney (AZR-MD-001 ointment/semi-solid drug)

Completed

Meibomian Gland Dysfunction

AZR-MD-001 ointment/semi-solid drug

Sydney, New South Wales, Australia

Fiona Stapleton

Apr 25, 2022

Meibomian Gland Dysfunction, Dry Eye Trial in Australia, Canada, New Zealand (AZR-MD-001 Low Dose, AZR-MD-001 Mid Dose,

Completed

Meibomian Gland Dysfunction
Dry Eye

AZR-MD-001 Low Dose
+3 more

Chatswood, New South Wales, Australia
+29 more

Nov 23, 2022